Lumida
/ATRC
⌘K
AtriCure Inc

AtriCure Inc

ATRC
$34.95USD↓-1.88%-0.67 today

MARKET CAP

1.8B

P/E (TTM)

3,495.0x

FWD P/E

324.9x

DAY RANGE

$35 – $36

52W RANGE

$25
$43

AI Summary

Stalk
Buy NowHigh

Stage 2 advancing regime and active Lockout Rally pattern reinforce a bullish medium-term bias, while the Lockout Rally override supersedes overbought timing concerns and permits immediate participation in the current breakout above key EMAs and prior highs.

  • ↑Q1 2026 revenue $141.2M (+14.3% YoY), U.S. up 14.9%.
  • ↑Box NOAF trial 300/960 patients enrolled, ahead of timeline.
  • ↓Profitability score deeply negative, indicating efficiency challenges.
Full analysis →

News for AtriCure Inc loads here via client-side fetch to /api/news/atrc.